AI Enhances Meibomian Gland Detection - Summary - MDSpire

AI Enhances Meibomian Gland Detection

AI-powered spectral imaging shown by proof-of-concept study to advance MGD diagnosis

  • June 16, 2026

  • 3 min

Share

Objective:

To evaluate a new hyperspectral imaging platform combined with AI for diagnosing meibomian gland dysfunction (MGD).

Approach:
    Key Findings:
    • MGD tissue exhibited distinct spectral signatures in specific wavelength ranges compared to healthy controls.
    • Spectral abnormalities correlated with clinical parameters such as tear break-up time and meibomian gland expressibility.
    • The SCNN chip allows for rapid, real-time spectral acquisition, making it more practical for clinical use.
    Interpretation:

    The findings suggest that hyperspectral imaging combined with AI could enhance the objective diagnosis of MGD, moving beyond traditional subjective assessments.

    Limitations:
    • Small sample size of 11 patients.
    • Study relied on ex vivo tissue sections rather than live imaging.
    Conclusion:

    Further studies with larger cohorts and in vivo imaging are necessary to validate the clinical viability of this diagnostic tool.

    Sources:

Original Source(s)

AI Enhances Meibomian Gland Detection

  • June 16, 2026

Related Content

Contact Lenses: Selecting RGP Material Properties

In this month’s column — part two in a two-part series — I present specific cases that highlight the considerations of these material properties.

Viewpoint: A fitting guide for contact lenses

In rereading Dr. Resnick's column, I was reminded of the many action steps provided in this, OM’s Annual Contact Lenses issue.

When Dry Eye Meets Contact Lenses

This article will delve into how to treat dry eye disease, and then explore how to refine selection and design of various contact lens modalities for patients with ocular surface disease.